These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21249604)

  • 1. Hemostatic disorders in type 1 diabetes mellitus.
    Targher G; Chonchol M; Zoppini G; Franchini M
    Semin Thromb Hemost; 2011 Feb; 37(1):58-65. PubMed ID: 21249604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].
    Udvardy M; Pósán E
    Orv Hetil; 1994 Sep; 135(37):2025-7. PubMed ID: 7936609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
    Blann AD; Lip GY
    Diabet Med; 1998 Aug; 15(8):634-42. PubMed ID: 9702464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of diet therapy on status of hemocoagulation and fibrinolysis in type 2 diabetes patients].
    Alekseeva RI; Meshcheriakova VA; Sharafetdinov KhKh; Plotnikova OA; Liutova LV; Karabasova MA; Andreenko GV
    Vopr Pitan; 2003; 72(5):18-21. PubMed ID: 14619610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
    Soedamah-Muthu SS; Chaturvedi N; Teerlink T; Idzior-Walus B; Fuller JH; Stehouwer CD;
    J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of pulse pressure with fibrinolysis in patients with type 2 diabetes.
    Wakabayashi I; Masuda H
    Thromb Res; 2007; 121(1):95-102. PubMed ID: 17439823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of exercise, coagulation, platelets, and fibrinolysis--a brief review.
    Bourey RE; Santoro SA
    Med Sci Sports Exerc; 1988 Oct; 20(5):439-46. PubMed ID: 3057308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in Type 1 diabetes: evidence for normal fibrinolytic state.
    Harmanci A; Kandemir N; Dagdelen S; Gonc N; Buyukasik Y; Alikasifoglu A; Kirazli S; Ozon A; Gurlek A
    J Diabetes Complications; 2006; 20(1):40-4. PubMed ID: 16389166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR; Skouby SO; Jespersen J
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period).
    Koert M; Nowak-Göttl U; Kreuz W; Grüttner HP; Kornhuber B; Breddin HK
    Klin Padiatr; 1991; 203(6):429-32. PubMed ID: 1721940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis.
    Tentolouris N; Boutati E; Karambakalis N; Perrea D; Tselepis AD; Tsoukala C; Kyriaki D; Lourida E; Anastasopoulou I; Karafoullidou A; Raptis SA; Katsilambros N
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):6-12. PubMed ID: 15871845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetes, coagulation and vascular events].
    Nenci GG; Paliani U
    Recenti Prog Med; 2000 Feb; 91(2):86-90. PubMed ID: 10748654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemostatic system in diabetes in children and in adults].
    Prochorow M; Fiederowicz-Fabrycy I; Sochacka-Kuzko B; Wichert K
    Pol Tyg Lek; 1977 Feb; 32(8):317-9. PubMed ID: 840755
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus.
    Zumbach M; Hofmann M; Borcea V; Luther T; Kotzsch M; Müller M; Hergesell O; Andrassy K; Ritz E; Ziegler R; Wahl P; Nawroth PP
    Exp Clin Endocrinol Diabetes; 1997; 105(4):206-12. PubMed ID: 9285207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the coagulation and fibrinolysis system in 54 patients with type 2 diabetes mellitus: correlations with lipid metabolism and blood glucose control].
    Moccia F; Colla G; Castelli F; Greco GM
    Clin Ter; 1996; 147(1-2):37-46. PubMed ID: 8767954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of the coagulation and fibrinolysis in non-insulin-dependent diabetes mellitus. In vivo study].
    Conti M; Marongiu F; Mameli G; Mamusa AM; Cambuli AB; Cossu E; Sorano GG; Biondi G; Cirillo R; Balestrieri A
    Recenti Prog Med; 1989 Jun; 80(6):297-9. PubMed ID: 2772395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.